"RNAi Global" Accelerate Biomedical Discovery Using Genome-Wide siRNA Screening

Harvard and Stanford Medical Schools and VUmc Join 12 International Research Centers and Dharmacon as Members of RNAi Global Initiative

17-Jul-2006 - The Genome-Wide RNAi Global Initiative (RNAi Global), an alliance of Dharmacon, Inc. and leading international research centers pioneering the use of whole-genome RNAi screening, today announced the addition of new members from Harvard Medical School, Stanford Medical School and the VU University ...

Dharmacon and amaxa collaborate to improve siRNA delivery into cells

08-Jun-2006 - Dharmacon, Inc., a business unit of the Fisher Biosciences group, and amaxa announced an agreement to co-promote data generated using Dharmacon's siRNA libraries with amaxa's Nucleofector® technology. Despite the rapid advance of RNAi gene silencing for drug discovery and development, some ...

Alnylam Grants Dharmacon License to Kreutzer-Limmer Patents for the RNA Interference Research Products Market

09-Jan-2006 - Alnylam Pharmaceuticals, Inc. and Dharmacon, Inc., a business unit of the Fisher Biosciences group, announced that Alnylam has granted Dharmacon a non-exclusive license to provide RNAi research products and services under the Kreutzer-Limmer patent family. This patent family, owned solely by ...

Dharmacon and 10 Research Institutes Establish Global Initiative to Advance Research Using Human-Genom-Wide siRNA Library

Founding Members Include Leading Biomedical Research Institutes in Six Countries

07-Oct-2005 - Dharmacon, Inc. announced the formation of the Genome-Wide RNAi Global Initiative, an alliance of leading international biomedical research centers. The initial goal of the Global Initiative is to accelerate the scientific and medical discoveries made possible by the recent availability of the ...

Dharmacon's completion of first human genome-wide siRNA library signals new era in life-science research

16-Aug-2005 - Dharmacon, Inc. announced the completion of the world's first genome-wide, short-interfering RNA (siRNA) library. The siARRAY® genome-wide library is the first complete library targeting genes across the entire human genome. Developed using Dharmacon's proprietary SMARTselection(TM) and ...

Dharmacon to deliver First Whole Human Genome-Wide siRNA Library

18-May-2005 - Dharmacon, Inc. announced an agreement to deliver a genome-wide short-interfering RNA (siRNA) library covering approximately 22.000 human genes to Millennium Pharmaceuticals, Inc. This library, the first siRNA collection targeting genes across the entire human genome, was developed using ...

Cancer Research UK Adopts Dharmacon Gene-Silencing Technology

21-Apr-2005 - Dharmacon, Inc. announced an agreement to provide siRNA libraries to Cancer Research UK. The siRNA libraries, which were developed using Dharmacon's proprietary SMARTselection(TM) and SMARTpool® technology platforms, initially include protein kinase genes and associated pathways. Cancer Research ...

Dharmacon RNAi Technology Selected by Genentech to support Drug Discovery Research

07-Feb-2005 - Dharmacon, Inc. announced that Genentech, Inc. has selected Dharmacon's advanced RNAi technology for use in its drug discovery and development research. Under an agreement between the two companies, Dharmacon will supply Genentech with a range of siRNA reagents including Dharmacon's Human ...

Dharmacon and Genospectra to Launch Genome-Wide Line of Novel RNA Assays for Gene Silencing Measurement

26-Jul-2004 - Dharmacon, Inc., the world's leading supplier of innovative RNA and RNA interference (RNAi) research products, and Genospectra, Inc., the exclusive supplier of QuantiGene(R) branched DNA (bDNA) gene expression profiling technology, announced an agreement to launch a genome-wide line of assays ...

Dharmacon Named Best Reagent Company at RNAi-2004-Boston Meeting on RNA

07-May-2004 - Lafayette and Waltham. Dharmacon, Inc., the leading global supplier of innovative RNA and RNA-interference (RNAi) research products, announced that it was named 'Best Reagent Company in the RNAi Field' at the second annual RNAi-2004-Boston Meeting on RNA Interference: Biology to Drugs & ...